Persistent Asset Partners »

Pyxis Oncology shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $77k 35k 2.22

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
UnitedHealth (UNH)
Regeneron Pharmaceuticals (REGN)
CVS Caremark Corporation (CVS)
Nebius Group Shs Class A (NBIS)
Pdd Holdings Sponsored Ads (PDD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Soleno Therapeutics (SLNO)
BioMarin Pharmaceutical (BMRN)
Labcorp Holdings Com Shs (LH)
Anthem (ELV)
Healthcare Services (HCSG)
Quest Diagnostics Incorporated (DGX)
Brightspring Health Svcs (BTSG)

View all positions for Persistent Asset Partners

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Tang Capital Management
Vanguard Group
Perceptive Advisors
Palo Alto Investors
Millennium Management
Stempoint Capital
BlackRock
Renaissance Technologies
Geode Capital Management
683 Capital Management
Driehaus Capital Management
UBS Group
Citadel Advisors

View all funds holding Pyxis Oncology